Companies
Companies
Alfasigma SpA’s €170m Deal Expands Filgotinib Business
📅 On January 2nd, 2024, Alfasigma SpA 💪 signed a €170m deal with Galapagos NV to expand their pipeline and market presence 🌍. Additionally, former Galapagos CCO, Michele Manto, joins Alfasigma as CCO Western Europe. 💼
AstraZeneca’s $12bn Chinese Biotech Power Move
🌍💊 AstraZeneca boosts cell therapy projects by acquiring Gracell Biotechnologies for $1.2bn to fight cancer and autoimmune diseases. 🦠🚀 Expected to close Q1 2024.
Bluebird Bio’s $150M Funding Revolutionizes Gene Therapy
💰 Bluebird Bio seeks $150m funding to support 💉 gene therapy launch. Exciting potential to transform treatment of genetic diseases! 🌍🚀🔬💸
Empowering Women in Biotech: BPI Hosts CGT Circle’s 10th Event
📢 BPI recently hosted the 10th event of CGT Circle, a female-focused networking group. Join us for empowering discussions! 💼💻🌟🚺
Metrion Biosciences Raises £37m to Boost Labs and Global Marketing
📢 Cambridge-based Metrion Biosciences raises £3.5m in equity financing to expand labs, invest in equipment, and enhance global marketing activities. 🌍🔬
Novartis Sells French Biomanufacturing Facility to Seqens Transforming It into a Leading CDMO
💼 Novartis sells its biomanufacturing facility in France to Seqens, who plans to expand it into a CDMO. 💪🔬
ReciBioPharm Boosts mRNA Therapy Manufacturing with Acuitas Partnership
📣 ReciBioPharm and Acuitas Therapeutics expand partnership to provide tech transfer and manufacturing services for mRNA-based therapeutics and vaccines. 🏭🔬
UK Biotech Company Receives Grant to Revolutionize Cell and Gene Therapy
📢 Exciting News! MicrofluidX receives UK grant to enhance its cell and gene therapy platform for improved scalability, cost-effectiveness, and efficiency. 💉🧬🚀
Major Milestone: Charles River & Vertex Revolutionize Cell Therapy Manufacturing
📅 Dec 18, 2023: Charles River Laboratories achieves milestone in manufacturing CASGEVY, first FDA-approved CRISPR therapy for sickle cell disease. 🙌🔬
BioNTech to Bring Life-Saving Vaccines to Africa
📢 BioNTech plans to establish a manufacturing facility in Rwanda for producing mRNA vaccines for Africa. 🏭🔬💰💉
